Form 4: TacticGem LLC Distributes Monopar Therapeutics Shares to Affiliates

TacticGem LLC distributed 1,433,334 shares of Monopar Therapeutics common stock to its affiliates, Gem Pharmaceuticals, LLC and Tactic Pharma, LLC, without consideration.

Summary

• TacticGem LLC, a significant shareholder of Monopar Therapeutics, has distributed a total of 1,433,334 common stock shares.
• The shares were distributed to two affiliated entities: Gem Pharmaceuticals, LLC (611,079 shares) and Tactic Pharma, LLC (822,255 shares).
• This distribution was made without any monetary consideration.
• The transaction was reported on December 9, 2024, and the filing was signed on December 17, 2024.

Sentiment

Score: 5

Explanation: The document describes a routine share transfer between related entities, which is neither positive nor negative for the company's performance. It's a neutral event from an investment perspective.

Industry Context

This transaction reflects internal restructuring within the ownership structure of Monopar Therapeutics' major shareholders, which is not uncommon in the biotech industry.

Comparison to Industry Standards

• Share distributions among affiliated entities are a common practice in corporate structures, especially when managing investments or preparing for potential future transactions.
• Similar transactions can be seen in other biotech companies where large shareholders may distribute shares to subsidiaries or related entities for various strategic reasons, such as tax planning or asset management.

Related Party Transactions

• The distribution of shares from TacticGem LLC to Gem Pharmaceuticals, LLC and Tactic Pharma, LLC constitutes a related party transaction.

Stakeholder Impact

• The share distribution does not directly impact the company's operations or financial position.
• The transaction may indirectly impact shareholders by altering the ownership structure of the company.

Key Dates

Keywords

Monopar Therapeutics, TacticGem LLC, share distribution, beneficial ownership, SEC Form 4, Gem Pharmaceuticals LLC, Tactic Pharma LLC